Whitehawk Therapeutics (WHWK)

• Market cap: $97.1M
• 1 day: -8.44%
• 5 days: -7.62%
• 1 month: -4.19%
• 3 months: 14.44%
• 6 months: 30.38%
• Year to date: -34.39%
• 1 year: -2.83%
• 5 years: -89.44%
• 10 years: -96.48%
• Sector: Healthcare
• Industry: Biotechnology

About: Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.

Employees: 21